sinoporphyrin sodium: a sensitizing agent for sonodynamic therapy; structure in first source [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 168012576 |
| MeSH ID | M0592270 |
| Synonym |
|---|
| 1820582-41-9 |
| AKOS040749504 |
| sinoporphyrin sodium |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 27 (72.97) | 24.3611 |
| 2020's | 10 (27.03) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 38 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| chloroquine | aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound | anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug | 2019 | 2019 | 5.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| paclitaxel | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent | 2017 | 2017 | 7.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 | |
| arginyl-glycyl-aspartic acid | oligopeptide | 2017 | 2019 | 6.0 | high | 0 | 0 | 0 | 0 | 2 | 0 | ||
| singlet oxygen | chalcogen; monoatomic oxygen; nonmetal atom | macronutrient | 2015 | 2019 | 7.7 | high | 0 | 0 | 0 | 0 | 3 | 0 | |
| cytochrome c-t | 2014 | 2014 | 10.0 | medium | 0 | 0 | 0 | 0 | 1 | 0 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Angiogenesis, Pathologic | 0 | 2015 | 2016 | 8.5 | low | 0 | 0 | 0 | 0 | 2 | 0 | |
| Anoxemia | 0 | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 | |
| Astrocytoma, Grade IV | 0 | 2019 | 2021 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 1 | |
| Atheroma | 0 | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 | |
| Benign Neoplasms | 0 | 2019 | 2020 | 4.5 | low | 0 | 0 | 0 | 0 | 2 | 0 | |
| Benign Neoplasms, Brain | 0 | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Body Weight | 0 | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 2 | 0 | |
| Brain Neoplasms | 0 | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Breast Cancer | 0 | 2015 | 2019 | 7.5 | low | 0 | 0 | 0 | 0 | 6 | 0 | |
| Breast Neoplasms | 0 | 2015 | 2019 | 7.5 | low | 0 | 0 | 0 | 0 | 6 | 0 | |
| Burns | 0 | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Cancer of Colon | 0 | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Cancer of Esophagus | 0 | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Cancer of Liver | 0 | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Cancer of Lung | 0 | 2016 | 2019 | 6.3 | low | 0 | 0 | 0 | 0 | 3 | 0 | |
| Cancer of Stomach | 0 | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 2 | |
| Carcinoma, Hepatocellular | 0 | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Carcinoma, Small Cell Lung | 0 | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Colonic Neoplasms | 0 | 2020 | 2020 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Colorectal Cancer | 0 | 2019 | 2020 | 4.5 | low | 0 | 0 | 0 | 0 | 2 | 0 | |
| Colorectal Neoplasms | 0 | 2019 | 2020 | 4.5 | low | 0 | 0 | 0 | 0 | 2 | 0 | |
| Dermatoses | 0 | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Disease Models, Animal | 0 | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 | |
| Esophageal Neoplasms | 0 | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Experimental Neoplasms | 0 | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Glial Cell Tumors | 0 | 2018 | 2020 | 5.0 | low | 0 | 0 | 0 | 0 | 3 | 0 | |
| Glioblastoma | 0 | 2019 | 2021 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 1 | |
| Glioma | 0 | 2018 | 2020 | 5.0 | low | 0 | 0 | 0 | 0 | 3 | 0 | |
| Hepatocellular Carcinoma | 0 | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Hypoxia | 0 | 2021 | 2021 | 3.0 | low | 0 | 0 | 0 | 0 | 0 | 1 | |
| Infections, Staphylococcal | 0 | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Liver Neoplasms | 0 | 2019 | 2019 | 5.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Lung Neoplasms | 0 | 2016 | 2019 | 6.3 | low | 0 | 0 | 0 | 0 | 3 | 0 | |
| Necrosis | 0 | 2020 | 2021 | 3.5 | low | 0 | 0 | 0 | 0 | 1 | 1 | |
| Neoplasms | 0 | 2019 | 2020 | 4.5 | low | 0 | 0 | 0 | 0 | 2 | 0 | |
| Sarcoma 180 | 0 | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Skin Diseases | 0 | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Small Cell Lung Carcinoma | 0 | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Staphylococcal Infections | 0 | 2017 | 2017 | 7.0 | low | 0 | 0 | 0 | 0 | 1 | 0 | |
| Stomach Neoplasms | 0 | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 2 |
| Article | Year |
|---|---|
| A safety study of a novel photosensitizer, sinoporphyrin sodium, for photodynamic therapy in Beagle dogs. Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, , Volume: 14, Issue:4 | 2015 |
| Article | Year |
|---|---|
| Sensitivity to antitubulin chemotherapeutics is potentiated by a photoactivable nanoliposome. Biomaterials, , Volume: 141 | 2017 |
| Article | Year |
|---|---|
| A new sensitizer DVDMS combined with multiple focused ultrasound treatments: an effective antitumor strategy. Scientific reports, , Dec-03, Volume: 5 | 2015 |